Prevalence of Antibiotic-Resistant Shigella spp. in Bangladesh: A Systematic Review and Meta-Analysis of 44,519 Samples
Antibiotics · 26.04.2023 · 12 (5) · 817
DOI: 10.3390/antibiotics12050817 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 26.04.2023. Verfasst von Saleh Ahmed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Shigella is the leading global etiological agent of shigellosis, especially in poor and underdeveloped or developing nations with insufficient sanitation such as Bangladesh. Antibiotics are the only treatment option for the shigellosis caused by Shigella spp. as no effective vaccine exists. However, the emergence of antimicrobial resistance (AMR) poses a serious global public health concern. Therefore, a systematic review and meta-analysis were conducted to establish the overall drug resistance pattern against Shigella spp. in Bangladesh. The databases of PubMed, Web of Science, Scopus, and Google Scholar were searched for relevant studies. This investigation comprised 28 studies with 44,519 samples. Forest and funnel plots showed any-drug, mono-drug, and multi-drug resistance. Any fluoroquinolone had a resistance rate of 61.9% (95% CI: 45.7–83.8%), any trimethoprim–sulfamethoxazole—60.8% (95% CI: 52.4–70.5%), any azithromycin—38.8% (95% CI: 19.6–76.9%), any nalidixic acid—36.2% (95% CI: 14.2–92.4%), any ampicillin—34.5% (95% CI: 25.0–47.8%), and any ciprofloxacin—31.1% (95% CI: 11.9–81.3%). Multi-drug-resistant Shigella spp. exhibited a prevalence of 33.4% (95% CI: 17.3–64.5%), compared to 2.6% to 3.8% for mono-drug-resistant strains. Since resistance to commonly used antibiotics and multidrug resistance were higher, a judicious use of antibiotics, the promotion of infection control measures, and the implementation of antimicrobial surveillance and monitoring programs are required to tackle the therapeutic challenges of shigellosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
- Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
- Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
- Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
- Department of Microbiology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
- Department of Chemistry, University of South Florida, 4202 E Fowler Ave, Tampa, FL 33620, USA.
ORCID-Profile: Saleh Ahmed, Md Asiful Islam
Zitieren
APA
Ahmed, S., Chowdhury, M. I. H., Sultana, S., Alam, S. S., Marzan, M., & Islam, M. A. (2023). Prevalence of Antibiotic-Resistant Shigella spp. in Bangladesh: A Systematic Review and Meta-Analysis of 44,519 Samples. Antibiotics, 12(5), 817. https://doi.org/10.3390/antibiotics12050817
Vancouver
Ahmed S, Chowdhury MIH, Sultana S, Alam SS, Marzan M, Islam MA. Prevalence of Antibiotic-Resistant Shigella spp. in Bangladesh: A Systematic Review and Meta-Analysis of 44,519 Samples. Antibiotics. 2023;12(5):817. doi:10.3390/antibiotics12050817
BibTeX
@article{Ahmed2023,
author = {Ahmed, Saleh and Chowdhury, Md Imrul Hasan and Sultana, Shabiha and Alam, Sayeda Sadia and Marzan, Mahfuza and Islam, Md Asiful},
title = {Prevalence of Antibiotic-Resistant Shigella spp. in Bangladesh: A Systematic Review and Meta-Analysis of 44,519 Samples},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {5},
pages = {817},
doi = {10.3390/antibiotics12050817}
}
EUVIMED